Projecten per jaar
Vingerafdruk
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
-
ANI389: Development of a B7-H3 nanoCAR-T cell therapy for recurrent glioblastoma (GlioCAR)
Neyns, B. (Administrative Promotor), Geeraerts, X. (CoI (Co-Promotor)), Tuyaerts, S. (CoI (Co-Promotor)), Breckpot, K. (CoI (Co-Promotor)), Duerinck, J. (CoI (Co-Promotor)) & Smolders, I. (CoI (Co-Promotor))
1/10/24 → 30/09/28
Project: Fundamenteel
-
AIIFUND115: Unraveling the spatial and longitudinal heterogeneity of glioblastoma tumors and its relationship with treatment response and patient survival
Movahedi, K. (Administrative Promotor), Geeraerts, X. (Medewerker) & Tuyaerts, S. (Medewerker)
1/01/24 → 31/12/27
Project: Fundamenteel
-
ANI352: MOTUNE-T-therapie: Metabolisch geoptimaliseerde TUNEd T-cellen als behandeling voor terugkerend glioblastoom
Neyns, B. (Administrative Promotor) & Geeraerts, X. (PI (Promotor, Principal Investigator))
1/10/23 → 1/06/28
Project: Fundamenteel
-
FWOTM772: Regulering van macrofaag metabolisme en functie door acidose in de tumor micro-omgeving
Van Ginderachter, J. (Administrative Promotor) & Geeraerts, X. (!!On behalf of)
1/10/15 → 30/09/20
Project: Fundamenteel
-
Elucidating the spatial heterogeneity of glioblastoma by integrating multimodal imaging with single-nucleus RNA sequencing
Srinivasan, A. N., Vara Pérez, M., De Sutter, S., Leduc, S., Geens, W., Geeraerts, X., Kancheva, D., Roelandt, R., Bruneau, M., Tuyaerts, S., Stevens, L., Neyns, B., Vandemeulebroucke, J., Duerinck, J. & Movahedi, K., 2025, (Unpublished). 1 blz.Onderzoeksoutput: Poster
-
Oncolytic HSV-1 expressing FLT3L kills melanoma, glioblastoma, and pancreatic cancer cells in vitro and induces immunogenic cell death.
Tuyaerts, S., Geeraerts, X., Reale, A., Stevens, L., Bertazzon, G., Brons, J., Janssen, T., Van Riet, I., Calistri, A. & Neyns, B., 18 sep. 2025, In: Molecular therapy. Oncology. 33, 3, 15 blz., 201031.Onderzoeksoutput: Article › peer review
Open AccessBestand1 Downloads (Pure) -
Proximity of macrophages to pancreatic basal cells suggest a role upon tissue remodeling in disease
Van Lint, S., Van der Vliet, M., Van den Bossche, J.-L., Van Laethem, J.-L., Messaoudi, N., Geeraerts, X., Baldan, J. & Rooman, I., 28 nov. 2025, (Unpublished).Onderzoeksoutput: Poster
-
A phase I clinical trial on the intracranial administration of autologous CD1c(BDCA-1)+ /CD141(BDCA-3)+ myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and nivolumab (NIVO) in patients with recurrent high-grade glioma (rHGG)
Neyns, B., Dirven, I., Lescrauwaet, L., Cammaert, M., Geens, W., Geeraerts, X., Stevens, L., Brock, S., Kockx, M., Everaert, H., Van Binst, A., Tuyaerts, S. & Duerinck, J., sep. 2024, In: Annals of Oncology. 35, blz. S406-S407 2 blz.Onderzoeksoutput: Meeting abstract (Journal)
Open Access -
A phase I trial on the intra- and post-operative intracranial administration of ipilimumab and nivolumab in patients with recurrent high-grade glioma.
Neyns, B., Dirven, I., Lescrauwaet, L., Del'haye, J. J. C., Geens, W., Geeraerts, X. & Stevens, L., 1 jun. 2024, In: Journal of Clinical Oncology. 42, 16, blz. 1-1 1 blz., 2037.Onderzoeksoutput: Meeting abstract (Journal)
Open AccessBestand12 Downloads (Pure)
Datasets
-
RNA sequencing human melanoma, glioblastoma and pancreatic adenocarcinoma cell lines
Tuyaerts, S. (Creator), Stevens, L. (Data Manager), Geeraerts, X. (Data Collector) & Neyns, B. (Supervisor), Gene Expression Omnibus (GEO), 21 aug. 2025
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288221
Dataset
Prijzen
-
Best Oral Presentation Award
Geeraerts, X. (Recipient), 8 feb. 2018
Prijs: Prize (including medals and awards)
Bestand -
Fundamenteel postdoctoraal mandaat STK
Geeraerts, X. (Recipient), 1 okt. 2023
Prijs: Fellowship awarded competitively
-
-
VIrBr Award - Best master Thesis in the category Bio-Engineering
Geeraerts, X. (Recipient), dec. 2014
Prijs: Prize (including medals and awards)
-
Wetenschappelijk Fonds Willy Gepts: FLT3L expressing HSV-1 derived oncolytic virus plus myeloid dendritic cells as a combination therapy for advanced melanoma patients refractory to immune checkpoint blockade.
Geeraerts, X. (Recipient), 2022
Prijs: Prize (including medals and awards)
Activiteiten
-
Academic Cell Manufacturing Workshop
Geeraerts, X. (Participant)
22 mei 2025Activiteit: Participation in workshop, seminar
-
MACS® Cell and Gene Therapy Days 2025
Geeraerts, X. (Participant)
4 nov. 2025 → 5 nov. 2025Activiteit: Participation in conference
-
Academic Cell Manufacturing Workshop
Geeraerts, X. (Speaker)
22 mei 2025Activiteit: Talk or presentation at a conference
-
In-depth characterization of the immune response upon COVID-19 vaccination in cancer patients (Evenement)
Geeraerts, X. (Jury)
24 nov. 2025Activiteit: Member of PhD committee
-
Knipsels
-
Ook dit is wetenschap: Xenia voert onderzoek naar nieuwe kankertherapieën
1/03/16
1 Mediabijdrage
Pers / media: !!Public Engagement Activities
-
Unesco honour for bioengineer
1/03/16
1 item van Media-aandacht
Pers / media: !!Public Engagement Activities
-
Meisjes & wetenschap: Omdat labjassen niet enkel mannen passen
2/02/16
1 Mediabijdrage
Pers / media: !!Public Engagement Activities
-
Women in Science Fellowship for Xenia Geeraerts (VIB/VUB)
1/12/15
1 Mediabijdrage
Pers / media: !!Public Engagement Activities
-
Xenia zoekt naar kankertherapieën
1/10/15
1 item van Media-aandacht
Pers / media: !!Public Engagement Activities
Scriptie
-
Karakterisering van myeloïde cellen tijdens de ontwikkeling van hepatocellulair carcinoom.
Geeraerts, X. ((PhD) Student), Van Ginderachter, J. (Promotor), Keirsse, J. (Advisor), Lahmar, Q. (Advisor) & Devoogdt, N. (Jury), Van Ginderachter, J. (Promotor), Keirsse, J. (Advisor), Lahmar, Q. (Advisor) & Devoogdt, N. (Jury), 5 sep. 2014Scriptie/Masterproef: Master's Thesis